Villalobos SJA, Facundo BS, Hernández CJR, Campos MA

Language: Spanish
References: 22
Page: 151-158
PDF size: 162.74 Kb.

ABSTRACT

Systemic lupus erythematosus (SLE) is an inflammatory disease that has an impact on multiple systems, is observed in multiple studies to the cardiac involvement occurs in 15% of patients, at some point in their natural history of disease is observed pericarditis by up to 23% in addition to myocarditis and endocarditis, no doubt this is often seen secondary to pericardial effusion, despite showing despite non-negligible percentage of heart disease is very uncommon to cause cardiac tamponade. Cardiac tamponade is a process in which increased pressure in the pericardial space, most often due to fluid accumulation, which can be an exudate hematic, serous or purulent, and less frequently gas, given the complications and timely diagnosis treatment have to be done quickly. For this reason we describe a case of a female in the sixth decade of life, which no previous medical history was admitted to the emergency room with a condition characterized by progressive dyspnea and chest pain based on clinical, radiologic and evolution she reach the diagnosis of cardiac tamponade, which subsequently based on additional studies corroborate that is secondary to lupus erythematosus.

REFERENCES

1. Gill JM, Quisel AN, Rocca PV, Walters DT. Diagnosis of systemic lupus erythematosus. Am Fam Phys 2003; 68: 2179-2182.

2. Pérez AF, Villagómez OA, Castro AM, Hernández SS. Taponamiento cardiaco como complicación de tuberculosis pericárdica. Reporte de un caso y revisión bibliográfica. Med Inter Méx 2009; 25: 81-88.

3. Jaume SS, Juan A, Antonia SG, Permayer-Miralda G. Hemodynamic effects of volume expansion in patients with cardiac tamponade. Circulation 2008; 117: 1545-1549.

4. Maisch B, Seferovic P, Ristic A, Erbel R. Guidelines on the diagnosis and management of pericardial diseases, executive summary. Eur Heart J 2004; 25: 587-610.

5. Gladman DD, Esdaile JM, Hahn BH, Klippel J. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthrit Rheum 1999; 42: 1785-1796.

6. Spodick DH. Acute cardiac tamponade. N Engl J Med 2003; 349: 684-690.

7. Collins D. A etiology and management of acute cardiac tamponade. Crit Care Resuscit 2004; 6: 54-58.

8. Manresa JM, Gutiérrez L, Viedma P, Alfani O. Taponamiento cardiaco como presentación clínica de lupus eritematoso sistémico. Rev Esp Cardiol 1997; 50: 600-602.

9. Rosales US, Castellanos CL, Galindo UJ. Alteraciones cardiacas en pacientes con lupus eritematoso sistémico y sospecha clínica de miocarditis: diagnóstico por resonancia magnética cardiovascular. Rev Mex Cardiol 2011; 22: 167-174.

10. Roy CL, Minor MA, Brookhart MA, Choidhry NK. Does this patient with a pericardial have cardiac tamponade? JAMA 2007; 297: 1810-1818.

11. Madhok R, Wu O. Systemic lupus erythematosus. Am Fam Phys 2007; 76: 1351-1353.

12. Schoenfeld MR, Messeloff CR. Cardiac tamponade in systemic lupus erythematosus. Circulation 1963; 27: 98-99.

13. Maisch B, Risti AD. The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep 2002; 4: 13-21.

14. Maisch B, Risti AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 2002; 23: 1503-1508.

15. Reydel B, Spodick DH. Frequency and significance of chamber collapses during cardiac tamponade. Am Heart J 1990; 119: 1160-1163.

16. Kochar GS, Jacobs LE, Kotler MN. Right atrial compression in postoperative cardiac patients: detection by transesophageal echocardiography. J Am Coll Cardiol 1990; 16: 511-516.

17. Torelli J, Marwick TH, Salcedo EE. Left atrial tamponade: diagnosis by transesophageal echocardiography. J Am Soc Echocardiogr 1991; 4: 413-414.

18. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994; 7: 665-668.

19. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest 2002; 122: 900-905.

20. Seo T, Ikeda Y, Onaka H et al. Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn Circ J 1993; 57: 489-494.

21. Fijalkowska A, Szturmowicz M, Tomkowski W et al. The value of measuring adenosine deaminase activity in pericardial effusion fluid for diagnosing the etiology of pericardial effusion. Pneumonol Alergol Pol 1996; 64(Suppl 2): 174-179.

22. Koh KK, Kim EJ, Cho CH et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 1994; 89: 2728-2735.